NeuBase Therapeutics Announces Receipt of Notice From Nasdaq

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the Listing

GlobeNewswireApr 6 04:05

Why Neubase Therapeutics (NBSE) Shares Are Nosediving

Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday's session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13

BenzingaMar 27 02:43

VERI, CHEK and CZOO Among Mid-day Movers

Seeking AlphaMar 27 00:55

NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics Among Healthcare Movers

Seeking AlphaMar 26 22:00

Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading

US stocks looked set to open modestly higher Tuesday as investors parsed durable goods and home price data and looked ahead to a key consumer confidence gauge. Dow Jones Industrial Average futures wer

MT NewswiresMar 26 21:29

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersStoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press rele

BenzingaMar 26 21:05